The Daily Papule

Monday 12 October

EJD
Successful cemiplimab treatment of functionally inoperable conjunctival squamous cell carcinoma avoiding the need for orbital exenteration.
Goller S, Seifert F, … senior author Gesierich AEuropean Journal of Dermatology
No abstractRead at publisher(opens in a new tab)
PCMRReview
Immune-Excluded Mucosal Melanoma
Spatial Mechanisms of Checkpoint Resistance and Biomarker-Guided Therapeutic Opportunities.
Truong-Balderas KM, Chang RC, … senior author Mansini APPigment Cell & Melanoma Research
Read at publisher(opens in a new tab)
JEADVLetter
Post-recurrence outcomes after observation or adjuvant anti-PD-1 therapy in nail apparatus melanoma.
Komori T, Nakano E, … senior author Matsushita SJournal of the European Academy of Dermatology and Venereology
No abstractRead at publisher(opens in a new tab)
EJDCase report
Lichen planus pemphigoides induced by pembrolizumab: a case report.
Bernardo D, Sousa M, … senior author Velho GCEuropean Journal of Dermatology
No abstractRead at publisher(opens in a new tab)

Sunday 11 October

JAAD IntObservational study
Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma
A Middle Eastern real-world study.
Alsarraf A, Boalbanat H, … senior author Tawab Hamed RAJAAD International
No abstractRead at publisher(opens in a new tab)

Saturday 10 October

Derm Pract ConceptObservational studyLetter
Tumor Size and Early Response to Sonidegib in Locally Advanced Basal Cell Carcinoma
A Real-Life Case Series.
De Giorgi V, Perillo G, … senior author Zuccaro BDermatology Practical & Conceptual
No abstractRead at publisher(opens in a new tab)
JID Innov
Temporal outcomes and biomarkers of rituximab treatment response in pemphigus
Validation of a historical control dataset.
Rujitharanawong C, Tongsai S, Payne ASJID Innovations
Read at publisher(opens in a new tab)
BJDObservational study
Impact of immunocompromised status on real-world outcomes with avelumab treatment in advanced Merkel cell carcinoma
findings from the prospective MCC-TRIM registry.
Becker JC, Mahmoudpour SH, … senior author Ugurel SBritish Journal of Dermatology
No abstractRead at publisher(opens in a new tab)

Thursday 8 October

JAAD
Bispecific antibody-associated desquamative palmoplantar dermatitis
a distinct palmoplantar toxicity beyond HFS and HFSR.
Nikolaou V, Sibaud VJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)
JAADReview
Comparison of efficacy and tolerability of hedgehog pathway inhibitors for locally advanced basal cell carcinoma
An expert opinion in the new age of immunotherapy.
Millan SH, Sun KH, … senior author Patel VAJournal of the American Academy of Dermatology
Read at publisher(opens in a new tab)

Wednesday 7 October

JAAD
Necrotic eruptions indicate severe myositis in immune checkpoint inhibitor-associated dermatomyositis.
Li W, Xu X, … senior author Yang JJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)
Clin Exp DermObservational study
Pemphigoid After Immune Checkpoint Inhibitors and Other Anti-Neoplastic Medications
A Danish Nationwide Case-Control Study.
Erichsen PA, Heerfordt IM, … senior author Horwitz HClinical and Experimental Dermatology
Read at publisher(opens in a new tab)

Monday 5 October

Melanoma ResLaboratory research
Comprehensive analysis and external validation of a glycolysis-related gene signature as a prognostic index for skin cutaneous melanoma.
Jiang C, Niu S, … senior author Tang XMelanoma Research
Read at publisher(opens in a new tab)

Saturday 3 October

Derm TherReview
Systemic Retinoids in Cutaneous T-Cell Lymphoma
A Scoping Review of Clinical Use and Evidence Gaps.
Bui T, Niknejad K, … senior author Rozati SDermatology and Therapy
Read at publisher(opens in a new tab)

Wednesday 30 September

Acta DVQuiz & image
Multiple Eruptive Facial Tumours in a 72-year-old Man Receiving Pembrolizumab: A Quiz.
Desjonqueres C, Sourty B, Maillard HActa Dermato-Venereologica
No abstractRead at publisher(opens in a new tab)
J Cutan PatholCase report
Disseminated Xanthogranuloma Harboring a GAB2::BRAF Fusion and MITF Pathogenic Variant Successfully Treated With Cobimetinib
A Rare Case Report.
Xu PC, Cushman-Vokoun AM, … senior author Pradhan DJournal of Cutaneous Pathology
Read at publisher(opens in a new tab)
Clin Exp DermObservational study
Autoimmune Bullous Disorders Associated With Immune Checkpoint Inhibitors
A Retrospective Review of a Single Center Cohort Over the Past Decade.
Cull D, Holder K, … senior author Sominidi Damodaran SClinical and Experimental Dermatology
Read at publisher(opens in a new tab)
Skin Health DisCase report
Polymorphous immunotherapy-induced cutaneous sarcoidosis.
Mackie L, Terlizzo M, … senior author Aguilar-Duran SSkin Health and Disease
Read at publisher(opens in a new tab)

Tuesday 29 September

JEADVObservational study
Immune-related adverse events with mogamulizumab in cutaneous T-cell lymphoma: A multicentre study.
Neubauer D, Palassin P, … senior author Samaran QJournal of the European Academy of Dermatology and Venereology
Read at publisher(opens in a new tab)

Monday 28 September

J Cutan PatholCase report
Bullous Eruption Associated With Loncastuximab Tesirine in a Patient With Diffuse Large B-Cell Lymphoma.
Jaguan D, Nguyen C, Choi JNJournal of Cutaneous Pathology
Read at publisher(opens in a new tab)

Journals and topics

Cancer drugs

Monday 12 October

Successful cemiplimab treatment of functionally inoperable conjunctival squamous cell carcinoma avoiding the need for orbital exenteration.

Immune-Excluded Mucosal Melanoma

Post-recurrence outcomes after observation or adjuvant anti-PD-1 therapy in nail apparatus melanoma.

Lichen planus pemphigoides induced by pembrolizumab: a case report.

Sunday 11 October

Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma

Saturday 10 October

Tumor Size and Early Response to Sonidegib in Locally Advanced Basal Cell Carcinoma

Temporal outcomes and biomarkers of rituximab treatment response in pemphigus

Impact of immunocompromised status on real-world outcomes with avelumab treatment in advanced Merkel cell carcinoma

Thursday 8 October

Bispecific antibody-associated desquamative palmoplantar dermatitis

Comparison of efficacy and tolerability of hedgehog pathway inhibitors for locally advanced basal cell carcinoma

Wednesday 7 October

Necrotic eruptions indicate severe myositis in immune checkpoint inhibitor-associated dermatomyositis.

Pemphigoid After Immune Checkpoint Inhibitors and Other Anti-Neoplastic Medications

Monday 5 October

Comprehensive analysis and external validation of a glycolysis-related gene signature as a prognostic index for skin cutaneous melanoma.

Saturday 3 October

Systemic Retinoids in Cutaneous T-Cell Lymphoma

Wednesday 30 September

Multiple Eruptive Facial Tumours in a 72-year-old Man Receiving Pembrolizumab: A Quiz.

Disseminated Xanthogranuloma Harboring a GAB2::BRAF Fusion and MITF Pathogenic Variant Successfully Treated With Cobimetinib

Autoimmune Bullous Disorders Associated With Immune Checkpoint Inhibitors

Polymorphous immunotherapy-induced cutaneous sarcoidosis.

Tuesday 29 September

Immune-related adverse events with mogamulizumab in cutaneous T-cell lymphoma: A multicentre study.

Monday 28 September

Bullous Eruption Associated With Loncastuximab Tesirine in a Patient With Diffuse Large B-Cell Lymphoma.